Punch Newspapers·4 min read·hard
Drugmakers' Finance Costs Jump 47% Amid High Interest Rates
A
Arinze Nwafor
✦AI Summary
Nigerian pharmaceutical companies listed on the Nigerian Exchange saw a 46.5% increase in finance costs during Q1 2026 due to high interest rates and increased debt. While some companies managed to grow operating profits, the rising cost of borrowing is putting significant pressure on sector profitability.
Industrial Pharmaceutical Supply Chain. Photo: ASC Software
businesseconomy
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in